B&B Tools AB

Pharming Group N.V. (AMS:PHARM) Leiden, The Netherlands, December 30, 2008. Biotech company Pharming Group NV ("Pharming" or "the Company") (NYSE Euronext: PHARM) today provided the following business update.

Pharming Group N.V. (AMS:PHARM) Leiden, The Netherlands, December 8, 2008. Biotech company Pharming Group NV ("Pharming" or "the Company") (NYSE Euronext: PHARM) announced today that it has reached an agreement with several holders of convertible bonds to cancel outstanding debt by payments in cash and shares.

Pharming Group N.V. (AMS:PHARM) Leiden, The Netherlands, December 1, 2008. Biotech company Pharming Group NV ("Pharming" or "The Company") (Euronext: PHARM) announced today that Prof. Dr. B.P.Th. Veltman has notified the Company that he will retire from the Board of Supervisory Directors ("BOSD") effective December 1, 2008. Reaching the age of 76, Dr. Veltman had already previously announced that he had plans to retire from the BOSD at the Annual General Meeting in 2009. Personal circumstances have led him to take this decision at this moment.

Pharming Group N.V. (AMS:PHARM) Key step in clinical program for ageing diseases

Pharming Group N.V. (AMS:PHARM) Pharming to receive significant milestone and royalty payments

Pharming Group N.V. (AMS:PHARM) Significant progress with lead product Rhucin®

Pharming Group N.V. (AMS:PHARM) Leiden, The Netherlands, October 13, 2008. Biotech company Pharming Group NV ("Pharming" or "The Company") (Euronext: PHARM) announced today the appointment of Dr Sijmen de Vries as Chief Executive Officer (CEO) of Pharming. This decision was taken by the Shareholders at an Extraordinary Meeting (EGM) held earlier today. Dr de Vries will take up his position as of November 3, 2008 as successor to Dr Francis J. Pinto who will retire at the next Annual General Meeting of Shareholders (AGM) of the Company in 2009. Until then, Dr Pinto will stay on as Non-Executive Chairman of the Management Board to ensure a smooth transition.

Pharming Group N.V. (AMS:PHARM) Dr Pinto to retire after completion of transition period

Pharming Group N.V. (AMS:PHARM) Database for Rhucin® Significantly Expanded

Pharming Group N.V. (AMS:PHARM) Leiden, The Netherlands, September 17, 2008. Biotech company Pharming Group NV ("Pharming" or "the Company") (NYSE Euronext: PHARM) today announced that it will present at the UBS Global Life Sciences Conference (September 22-25, 2008) in New York.